The company is currently in the process of merging with a suitable USA or a China based operating candidate in the similar industry as the issuer. There is no reverse split planned for the company, nor any toxic financing planned. The company has made available sufficient funds and resources available through its preferred shareholder, to be a vibrant and operational company.